ENDRA Life Sciences (NDRA) Competitors $3.09 -0.01 (-0.32%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.11 +0.02 (+0.61%) As of 05/21/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NDRA vs. LYRA, TNON, AEMD, IINN, PSTV, CHEK, BLAC, QNRX, AMIX, and NUWEShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include Lyra Therapeutics (LYRA), Tenon Medical (TNON), Aethlon Medical (AEMD), Inspira Technologies Oxy B.H.N. (IINN), Plus Therapeutics (PSTV), Check-Cap (CHEK), Bellevue Life Sciences Acquisition (BLAC), Quoin Pharmaceuticals (QNRX), Autonomix Medical (AMIX), and Nuwellis (NUWE). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Lyra Therapeutics Tenon Medical Aethlon Medical Inspira Technologies Oxy B.H.N. Plus Therapeutics Check-Cap Bellevue Life Sciences Acquisition Quoin Pharmaceuticals Autonomix Medical Nuwellis ENDRA Life Sciences (NASDAQ:NDRA) and Lyra Therapeutics (NASDAQ:LYRA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Which has more volatility and risk, NDRA or LYRA? ENDRA Life Sciences has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, Lyra Therapeutics has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500. Does the media favor NDRA or LYRA? In the previous week, ENDRA Life Sciences had 2 more articles in the media than Lyra Therapeutics. MarketBeat recorded 2 mentions for ENDRA Life Sciences and 0 mentions for Lyra Therapeutics. Lyra Therapeutics' average media sentiment score of 0.00 beat ENDRA Life Sciences' score of -1.50 indicating that Lyra Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment ENDRA Life Sciences Very Negative Lyra Therapeutics Neutral Does the MarketBeat Community believe in NDRA or LYRA? ENDRA Life Sciences received 213 more outperform votes than Lyra Therapeutics when rated by MarketBeat users. Likewise, 62.86% of users gave ENDRA Life Sciences an outperform vote while only 58.54% of users gave Lyra Therapeutics an outperform vote. CompanyUnderperformOutperformENDRA Life SciencesOutperform Votes23762.86% Underperform Votes14037.14% Lyra TherapeuticsOutperform Votes2458.54% Underperform Votes1741.46% Do institutionals & insiders have more ownership in NDRA or LYRA? 1.2% of ENDRA Life Sciences shares are held by institutional investors. Comparatively, 95.6% of Lyra Therapeutics shares are held by institutional investors. 0.0% of ENDRA Life Sciences shares are held by company insiders. Comparatively, 3.3% of Lyra Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is NDRA or LYRA more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to Lyra Therapeutics' net margin of -6,635.76%. Lyra Therapeutics' return on equity of -125.07% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -127.39% -103.77% Lyra Therapeutics -6,635.76%-125.07%-59.74% Do analysts rate NDRA or LYRA? ENDRA Life Sciences currently has a consensus price target of $50.00, suggesting a potential upside of 1,544.74%. Lyra Therapeutics has a consensus price target of $2.00, suggesting a potential upside of 2,069.20%. Given Lyra Therapeutics' higher probable upside, analysts plainly believe Lyra Therapeutics is more favorable than ENDRA Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Lyra Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has higher earnings & valuation, NDRA or LYRA? ENDRA Life Sciences has higher earnings, but lower revenue than Lyra Therapeutics. Lyra Therapeutics is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$10.06M-$172.04-0.02Lyra Therapeutics$1.19M5.16-$62.68M-$1.21-0.08 SummaryENDRA Life Sciences and Lyra Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.71M$3.27B$5.36B$8.40BDividend YieldN/A1.73%5.22%4.11%P/E Ratio0.0017.0926.6219.74Price / SalesN/A85.42391.30117.36Price / CashN/A44.0938.2534.62Price / Book0.003.776.804.51Net Income-$10.06M$94.03M$3.23B$248.18M7 Day Performance-2.88%3.67%4.02%1.07%1 Month Performance-9.52%27.88%12.19%14.96%1 Year Performance-99.99%-11.46%17.04%6.70% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences1.6492 of 5 stars$3.09-0.3%$50.00+1,518.1%-100.0%$1.74MN/A0.0020Negative NewsLYRALyra Therapeutics2.0301 of 5 stars$0.11-4.3%$2.00+1,770.9%-73.6%$7.08M$1.19M-0.0750Gap UpTNONTenon Medical1.3992 of 5 stars$1.12+0.9%$4.67+316.7%+49.3%$6.94M$3.28M-0.048Gap DownAEMDAethlon Medical1.6942 of 5 stars$0.41+3.0%$7.00+1,587.2%-8.8%$6.66M$570,000.00-0.2610IINNInspira Technologies Oxy B.H.N.0.29 of 5 stars$0.51+0.1%N/A-77.2%$6.43MN/A0.0020PSTVPlus Therapeutics1.2407 of 5 stars$0.34-19.0%$11.50+3,282.4%-84.1%$5.78M$4.91M-0.1320CHEKCheck-Cap0.4015 of 5 stars$0.88-4.9%N/A-60.2%$5.15MN/A-0.2980News CoverageAnalyst ForecastGap DownBLACBellevue Life Sciences AcquisitionN/A$1.17+2.6%N/A-89.5%$4.73MN/A0.00N/AQNRXQuoin Pharmaceuticals0.347 of 5 stars$7.99+3.8%N/A-67.7%$4.70MN/A-1.974AMIXAutonomix Medical2.2788 of 5 stars$1.87-4.1%$16.50+782.4%-96.0%$4.61MN/A-0.141NUWENuwellis2.4992 of 5 stars$0.96+2.1%$17.00+1,670.8%-90.1%$4.20M$8.74M-0.0170 Related Companies and Tools Related Companies Lyra Therapeutics Competitors Tenon Medical Competitors Aethlon Medical Competitors Inspira Technologies Oxy B.H.N. Competitors Plus Therapeutics Competitors Check-Cap Competitors Bellevue Life Sciences Acquisition Competitors Quoin Pharmaceuticals Competitors Autonomix Medical Competitors Nuwellis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NDRA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NDRA Stock Free NDRA Stock Alerts